Delivery Order SPE2DR25D9129-SPE2DR26FJGB9
- Not listed
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, for YF-VAX 1 dose vials, with a ceiling value of $5,036.32. DMS Pharmaceutical Group is a woman-owned small business. The order is issued under the company's single-award Indefinite Delivery Contract with DLA under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials with a ceiling value of $5,036.32. DMS Pharmaceutical Group is a woman-owned small business. The delivery order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract that authorizes firm fixed-price orders for pharmaceuticals and medical consumables to support Department of...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 5, 2026, with a ceiling value of $1,888.62 for YF-VAX 1 dose vials, with ultimate completion by February 27, 2026. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999...
- The Defense Logistics Agency issued a $3,147.70 delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is placed under a single-award Indefinite Delivery Contract with a $500 million ceiling awarded to DMS on November 13, 2025, with an ultimate completion date of December 31, 2036. PPV-G GEN V is a Defense...
- <p>The Defense Logistics Agency issued a $1,259.08 delivery order to DMS Pharmaceutical Group Inc. on February 9, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of March 3, 2026.</p>
- <p>The Defense Logistics Agency issued a $3,777.24 delivery order to DMS Pharmaceutical Group Inc. on February 7, 2026, for YF-VAX 1 dose vials under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is firm fixed price with an ultimate completion date of March 2, 2026. Place of performance is Park Ridge, IL.</p>
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing with no set-aside designation. This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under the agency's...
- On August 12, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 3, 2025, and no set-aside designation was applied to this award....
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 30, 2025. This firm fixed-price delivery order was issued on September 9, 2025, with no set-aside designation applied. The order will be fulfilled from the awardee's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that serves as a critical supplier...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on January 22, 2026, with an ultimate completion date of February 12, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation. The delivery order is issued under the company's single-award Indefinite...
- SPE2DR25D9129Indefinite Delivery Contract
- SPE2DR25D9129-SPE2DR26FJGB9Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 10, 2026, for YF-VAX 1 dose vials with a ceiling value of $1,753.28. The order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. That IDC, awarded November 13, 2025, has a $499.999 billion ceiling and authorizes DLA to issue firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally through December 31, 2036. Place of performance is Park Ridge, Illinois. The order is firm fixed price with an ultimate completion date of March 4, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/9/26 |